iZafe Group AB (publ) (STO:IZAFE.B)
0.2580
+0.0010 (0.39%)
Jun 23, 2025, 5:11 PM CET
iZafe Group AB Company Description
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home.
The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses.
It also offers Pilloxa, a platform that provides real-time insights and improved data quality to empower and motivate patients.
The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019.
iZafe Group AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
iZafe Group AB (publ)
Country | Sweden |
Founded | 2008 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 7 |
CEO | Anders Segerstrom |
Contact Details
Address: David Bagares Gata 3 Stockholm, 111 38 Sweden | |
Phone | 46 8 21 11 21 |
Website | izafe.se |
Stock Details
Ticker Symbol | IZAFE.B |
Exchange | Nasdaq Stockholm |
Share Class | Class B Shares |
Fiscal Year | January - December |
Reporting Currency | SEK |
ISIN Number | SE0003656834 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Anders Segerstrom | Chief Executive Officer |
Barbro Stahle Sjonell | Co-Founder |
Marius Sandberg | Chief Financial Officer |
Mikael Svensson | Chief Operating Officer |
Erik Gillsbro | Chief Technology Officer |
Helena Ronnqvist | CMO and BUM of Pilloxa |